
Matthias Evers, Ph.D., Joins IMIDomics’ Board of Directors
Key Highlights
- Matthias Evers, Ph.D., appointed as an independent director at IMIDomics.
- Dr. Evers brings decades of expertise in life sciences, drug development, and biotech strategy.
- His experience aligns with IMIDomics' data-driven approach to developing precision therapies.
Source: Business Wire
Notable Quotes
“ IMIDomics' integration of multi-omics data with clinical insights presents a massive opportunity to accelerate the development of precision therapies. ”
Dr. Matthias Evers, Independent Director at IMIDomics, Inc
“ His deep experience in fostering innovative partnerships and driving life sciences discoveries to the market aligns perfectly with our focus on advancing our pharmaceutical pipeline. ”
Dr. Fred Craves, Chairman and CEO at IMIDomics
Heading
Ginkgo Bioworks Launches Protein LLM and Model API Powered by Google Cloud News Product News Read More Chris-Anne Roque Courtney Green Appointed as QGenda’s First VP of Nurse and Staff Solutions Hiring News News Read More Chris-Anne Roque Vyne Medical® Acquires Extract Systems® to Enhance Healthcare Automation News Partnership News Read More Chris-Anne Roque PatientPay Partners with Azalea Health to Streamline Billing for Ambulatory Providers News Partnership News Read More Chris-Anne Roque Raven Health and Flychain Announce Strategic Partnership to Revolutionize Financial Operations for ABA Therapy Providers News Partnership News Read More Chris-Anne Roque Nura Bio Secures $140M in Series A Financing and Appoints Shilpa Sambashivan, Ph.D., as CEO Funding News News Read More Chris-Anne Roque